| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
771 |
733 |
$173K |
| 80053 |
Comprehensive metabolic panel |
30,362 |
20,328 |
$155K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
3,313 |
2,716 |
$102K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
29,981 |
20,022 |
$85K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
2,785 |
2,392 |
$66K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
336 |
279 |
$57K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
1,484 |
1,057 |
$35K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
985 |
930 |
$33K |
| 84443 |
Thyroid stimulating hormone (TSH) |
3,965 |
3,559 |
$32K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,379 |
1,333 |
$31K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
7,262 |
3,172 |
$30K |
| 83735 |
|
7,807 |
3,333 |
$26K |
| 85027 |
|
8,703 |
4,562 |
$25K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
500 |
469 |
$19K |
| 83690 |
|
4,829 |
3,918 |
$16K |
| 87040 |
|
1,532 |
1,124 |
$16K |
| 84484 |
|
3,146 |
2,582 |
$15K |
| 84703 |
|
3,847 |
3,485 |
$14K |
| 81001 |
|
9,872 |
8,568 |
$14K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
1,807 |
1,586 |
$13K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
2,334 |
2,048 |
$12K |
| 82962 |
|
6,679 |
2,679 |
$12K |
| 85610 |
|
5,657 |
3,302 |
$11K |
| 82607 |
|
1,747 |
1,552 |
$10K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
171 |
151 |
$10K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
138 |
124 |
$10K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
314 |
259 |
$10K |
| 86140 |
|
3,881 |
2,133 |
$9K |
| 86850 |
|
2,940 |
2,490 |
$8K |
| 80061 |
Lipid panel |
2,355 |
2,092 |
$8K |
| 86901 |
|
3,402 |
2,827 |
$8K |
| 87581 |
|
335 |
278 |
$8K |
| 87486 |
|
334 |
277 |
$8K |
| 85379 |
|
2,005 |
1,425 |
$8K |
| 82746 |
|
1,270 |
1,121 |
$7K |
| 84439 |
|
1,584 |
1,401 |
$7K |
| 81025 |
|
3,590 |
3,126 |
$7K |
| 82550 |
|
2,363 |
1,971 |
$7K |
| 85730 |
|
2,230 |
1,818 |
$7K |
| 87186 |
|
1,065 |
867 |
$6K |
| 87631 |
|
120 |
112 |
$6K |
| 84466 |
|
1,364 |
1,172 |
$6K |
| 86900 |
|
3,407 |
2,827 |
$6K |
| 83605 |
|
1,196 |
880 |
$6K |
| 82553 |
|
1,446 |
1,302 |
$5K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,699 |
1,525 |
$5K |
| 83880 |
|
473 |
390 |
$5K |
| 82728 |
|
1,262 |
1,059 |
$5K |
| 82803 |
|
589 |
353 |
$5K |
| 83615 |
|
1,808 |
1,142 |
$5K |
| 83540 |
|
1,424 |
1,213 |
$4K |
| 85007 |
|
2,163 |
1,296 |
$4K |
| 87641 |
|
161 |
127 |
$4K |
| 87070 |
|
890 |
674 |
$3K |
| 85652 |
|
2,066 |
1,644 |
$3K |
| 84702 |
|
602 |
515 |
$3K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
101 |
92 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
286 |
262 |
$2K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
41 |
34 |
$2K |
| 83970 |
|
133 |
98 |
$2K |
| 87075 |
|
317 |
247 |
$2K |
| 84100 |
|
931 |
457 |
$2K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
85 |
80 |
$2K |
| 82570 |
|
839 |
726 |
$2K |
| 87205 |
|
781 |
591 |
$1K |
| 87077 |
|
180 |
106 |
$1K |
| 87081 |
|
288 |
268 |
$800.40 |
| 83498 |
|
96 |
85 |
$771.24 |
| 83516 |
|
135 |
124 |
$721.36 |
| 87807 |
|
141 |
138 |
$638.81 |
| 85018 |
|
546 |
456 |
$620.81 |
| 84550 |
|
288 |
200 |
$597.25 |
| 83021 |
|
87 |
77 |
$554.19 |
| 82077 |
|
53 |
43 |
$549.08 |
| 85014 |
|
464 |
398 |
$524.97 |
| 87340 |
|
60 |
49 |
$398.25 |
| 80076 |
|
105 |
52 |
$367.25 |
| 84030 |
|
119 |
92 |
$294.56 |
| 82261 |
|
34 |
31 |
$280.50 |
| 82140 |
|
63 |
38 |
$275.31 |
| 84481 |
|
56 |
37 |
$274.34 |
| 80050 |
General health panel |
396 |
354 |
$255.60 |
| 83789 |
|
34 |
31 |
$245.82 |
| 84156 |
|
165 |
132 |
$192.18 |
| 84403 |
|
13 |
13 |
$176.96 |
| 82248 |
|
76 |
54 |
$156.33 |
| 82776 |
|
34 |
31 |
$119.68 |
| 86803 |
|
12 |
12 |
$101.04 |
| 82150 |
|
25 |
16 |
$79.75 |
| 86880 |
|
29 |
27 |
$75.60 |
| 87088 |
|
14 |
13 |
$74.32 |
| 82565 |
|
31 |
26 |
$72.23 |
| 86308 |
|
24 |
24 |
$57.60 |
| 82784 |
|
13 |
12 |
$54.48 |
| 86592 |
|
26 |
25 |
$54.00 |
| 84134 |
|
13 |
12 |
$50.99 |
| 84145 |
|
371 |
220 |
$42.68 |
| 84132 |
|
16 |
14 |
$33.36 |
| 85045 |
|
14 |
13 |
$18.34 |
| 80320 |
|
41 |
33 |
$0.00 |